AgreementAgreement • August 1st, 2024 • REGENXBIO Inc. • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledAugust 1st, 2024 Company Industry JurisdictionThis Consulting and Employment Separation Agreement (the “Agreement”) is entered into as of June 12, 2024, by and between REGENXBIO Inc. (“REGENXBIO”), a Delaware corporation with offices at 9804 Medical Center Drive, Rockville, Maryland 20850, and Ken Mills (“Mr. Mills”), (each a “Party” and collectively the “Parties”).
ContractEmployment Agreement • August 1st, 2024 • REGENXBIO Inc. • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledAugust 1st, 2024 Company Industry JurisdictionThis Employment Agreement (this "Agreement") is entered into and made effective as of July 1. 2024, by and between Curran Simpson (the "Employee") and REGENXBIO Inc., a Delaware corporation (the "Company").